Company with platform technology, called CombiSNiP, that genetically quantifies an individual's risk for development, and is involved in pharmacogenetics research on treating breast cancer. Includes corporate overview, directions and contacts in Oklahoma City.

Category
Cancer
Visits
400
Added
May 6, 2026
Rating
(1)
Rate This Site
QR Code
QR code Download PNG
Embed Badge
Place this code on your website to show you're listed here.
Get the best links delivered weekly — hand-picked from 1,200,429 resources